CN101643456B - Synthesis method of symmetric 1, 3, 4-oxadiazole - Google Patents

Synthesis method of symmetric 1, 3, 4-oxadiazole Download PDF

Info

Publication number
CN101643456B
CN101643456B CN2009100674766A CN200910067476A CN101643456B CN 101643456 B CN101643456 B CN 101643456B CN 2009100674766 A CN2009100674766 A CN 2009100674766A CN 200910067476 A CN200910067476 A CN 200910067476A CN 101643456 B CN101643456 B CN 101643456B
Authority
CN
China
Prior art keywords
water
room temperature
minutes
stirred
oxadiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100674766A
Other languages
Chinese (zh)
Other versions
CN101643456A (en
Inventor
朱东霞
芦红飞
张静
张景萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeast Normal University
Original Assignee
Northeast Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Normal University filed Critical Northeast Normal University
Priority to CN2009100674766A priority Critical patent/CN101643456B/en
Publication of CN101643456A publication Critical patent/CN101643456A/en
Application granted granted Critical
Publication of CN101643456B publication Critical patent/CN101643456B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention provides a synthesis method of symmetric 1, 3, 4-oxadiazole, which comprises the following steps: obtaining symmetric hydrazide by one-step reaction with hydrazine hydrate after acylating carboxylic acid; refluxing the symmetric hydrazide in a POC1<3> solvent for 10 hours; after the reaction system is cooled to room temperature, slowly and dropwisely adding the solution in ice water; after the reaction solution adding, keeping static until all the while solid precipitates; carrying out the suction filtration, and washing with water to obtain the pure objective product. The symmetric hydrazide can be directly obtained by the method; the cyclization reaction is directly carried out; the obtained substance is treated with water so as to obtain the pure objective product, namely symmetric 1, 3, 4-oxadiazole. The method has few steps; the solvent used in the purifying process of the product is water, rather than an organic solvent; the yield of every step of the whole synthesis procedure is very high; and therefore, the chemical reaction is economical and protects the environment.

Description

A kind of symmetrical 1,3, the synthetic method of 4-oxadiazole
Technical field:
The present invention discloses a kind of symmetrical 1,3, and the synthetic method of 4-oxadiazole for a kind of new organic compound synthetic method, belongs to the organic chemistry synthesis technical field.
Background technology:
Publish thesis from M.S.Gibson in 1962 and to have developed 1,3, (Tetrahedron, 1962, V (18): 1377-1380) since the reaction mechanism of 4-oxadiazole cyclization, people constantly adopt novel method synthetic 1,3,4-oxadiazole derivative, wherein synthetic have 1 of a symmetrical structure, 3, the main method of 4-oxadiazole derivative has:
1) thiosemicarbazide and aromatic carboxylic acid---see 1. (chemical reagent of formula, 1997,19 (6): 373-381.), perhaps Urea,amino-and aromatic carboxylic acid---see 2. (Synth.Commun. of formula, 2002,32 (21): 3339-3345.), under the effect of polyphosphoric acid (PPA), carry out cyclization and make symmetric 1,3,4-oxadiazole compound;
Figure G2009100674766D00011
2) the bishydrazide cyclization make symmetric 1,3,4-oxadiazole compound.
With carboxylic acid and the synthetic ester of alcohol reaction, ester and hydrazine hydrate reaction generate hydrazides, and hydrazides and acyl chloride reaction generate symmetric bishydrazide---see that formula is 1..Perhaps hydrazides and carboxylic acid react and generate symmetric bishydrazide---see that formula is 2..It is symmetric 1,3 that the bishydrazide cyclization makes, 4-oxadiazole compound.
Figure G2009100674766D00012
Figure G2009100674766D00021
3) tetrazole and acylate rearrangement reaction obtain 1,3,4-oxadiazole compound.(J.org.chem.,2001,66:4062-4064.)
Figure G2009100674766D00022
All exist some shortcoming and defect in the above-mentioned existing synthetic technology:
Method 1) does the dewatering agent reaction at polyphosphoric acid and synthesize 1,3, during the 4-oxadiazole, easily cause side reactions such as coking or degraded because of temperature control is improper.
Method 2) with the synthetic ester of carboxylic acid and alcohol reaction, ester and hydrazine hydrate reaction generate hydrazides, and hydrazides and generate the symmetric double hydrazides with acyl chloride reaction sees that formula 1..Perhaps, hydrazides and carboxylic acid react and generate symmetric hydrazides, see that formula 2..Carry out cyclization at last and obtain 1,3, the 4-oxadiazole.Each step productive rate of this method all is far smaller than 90%, and the final product that obtains needs column chromatography to purify.
Method 3) carboxylic acid is obtained acyl chlorides through after the acidylate, obtain acylate with corresponding tetrazole reaction then, then carrying out cyclization again obtains 1,3, the 4-oxadiazole.Desired raw material in this method---tetrazole is synthetic very complicated, and resulting final product need be purified through column chromatography.
In sum, existing technology: the first, side reactions such as coking or degraded easily take place when making dewatering agent with polyphosphoric acid.The second, the route complexity---need at least through four steps, and the productive rate of each step product all is far smaller than 90%, just can obtains target product, involve great expense.The 3rd, resulting material demand is purified with a large amount of organic solvents, causes the expense of entire synthesis process to raise like this, causes serious environmental to pollute simultaneously.
Summary of the invention:
The present invention discloses a kind of symmetrical 1,3, and the synthetic method of 4-oxadiazole has overcome the synthetic method operational path complexity of existing such compound, and synthetic product yields poorly, and environmental pollution seriously waits shortcoming.
Synthetic route of the present invention is as follows:
Figure G2009100674766D00031
Concrete synthetic method is as follows:
The carboxylic acid that takes by weighing 5-10mol places flask, adds the SOCl of 5-10mL 2Refluxed 10 hours down at 78 ℃, cool to room temperature, decompression steams unnecessary SOCl 2, airtight being placed in the frozen water of flask stirred 5 minutes.Slowly drip the hydrazine hydrate of 2-5mL80% then, dropping to does not have white smoke to generate.At room temperature stirred after dropwising 10 minutes, and added 20-30mL water then in flask, stirred 30 minutes, suction filtration obtains white solid matter on filter paper.Its drying is placed in the flask, and then adds the POCl of 10-15mL 3, refluxing 10 hours down at 100 ℃, cool to room temperature is added drop-wise to (stirring) in the frozen water to its settled solution, after dropwising, leaves standstill to solid complete
Portion separates out, and suction filtration washes with water 3-4 time then, obtains white solid on filter paper, after the drying promptly.
The advantage of synthesis technique of the present invention is as follows: each the step purification process in the building-up process only need wash with water and get final product, synthetic route is short, do not need to purify with column chromatography, save a large amount of organic solvents, and the productive rate of each step gained target product surpasses 90%, building-up process cheap, the safety and environmental protection of cost economy simple to operate, synthetic.
Description of drawings
Fig. 1 is the H-NMR figure of embodiment 1;
Fig. 2 is the X-single crystal diffraction unit cell figure of embodiment 1;
Fig. 3 is the IR figure of embodiment 1.
Fig. 4 is the H-NMR figure of embodiment 2;
Fig. 5 is the X-single crystal diffraction unit cell figure of embodiment 2;
Fig. 6 is the IR figure of embodiment 2.
Fig. 7 is the H-NMR figure of embodiment 3;
Fig. 8 is the IR figure of embodiment 3.
Fig. 9 is the H-NMR figure of embodiment 4;
Figure 10 is the IR figure of embodiment 4.
Embodiment
Further describe this synthetic method in following embodiment, described embodiment only is used for illustration purpose, and is not intended to the use range of restriction present method.
Embodiment 1:
2,5-two (2-methoxyl group) phenyl-1,3,4-oxadiazole synthetic.
With 1.52g (10mmol) o-methoxybenzoic acid, 5mL SOCl 2, join in the 50mL flask.At 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, airtight flask, be placed in the frozen water and stirred 5 minutes.Open wide flask, slowly drip the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, add 20mL water then in flask, stirred 30 minutes, suction filtration obtains white solid matter on filter paper.Its drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature, its settled solution slowly is added drop-wise to (stirring) in the frozen water, after dropwising, leave standstill to solid and all separate out suction filtration, wash with water 3-4 time, on filter paper, obtain white solid, promptly get after the drying purified 2,5-two (2-methoxyl group) phenyl-1,3, the 4-oxadiazole.Synthetic route is as follows:
The gained material characterizes as follows through nuclear-magnetism (H-NMR), X-monocrystal diffraction, infrared spectra (IR): H-NMR figure sees Fig. 1; X-single crystal diffraction unit cell figure sees Fig. 2; IR figure sees Fig. 3.
Embodiment 2
2,5-two (2-thienyl)-1,3,4-oxadiazole synthetic.
With 1.28g (10mmol) 2-thiophenic acid, 5mL SOCl 2, join in the 50mL flask.At 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, airtight flask, be placed in the frozen water and stirred 5 minutes.Open wide flask, slowly drip the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, add 20mL water in flask, stirred 30 minutes, suction filtration obtains white solid matter on filter paper.Its drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature, its settled solution slowly is added drop-wise to (stirring) in the frozen water, after dropwising, leave standstill to solid and all separate out suction filtration, wash with water 3-4 time, on filter paper, obtain white solid, promptly get after the drying purified 2,5-two (2-thienyl)-1,3, the 4-oxadiazole.Synthetic route is as follows:
Figure G2009100674766D00051
The gained material characterizes as follows through nuclear-magnetism (H-NMR), X-monocrystal diffraction, infrared spectra (IR):
H-NMR figure sees Fig. 4.X-single crystal diffraction unit cell figure sees Fig. 5.IR figure sees Fig. 6.
Embodiment 3
2,5-phenylbenzene-1,3,4-oxadiazole synthetic.
With 1.22g (10mmol) phenylformic acid, 5mL SOCl 2, join in the 50mL flask.At 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, airtight flask, in frozen water, stirred 5 minutes.Open wide flask, slowly drip the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, add 20mL water in flask, stirred 30 minutes, suction filtration obtains white solid matter on filter paper.Its drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature, its settled solution slowly is added drop-wise to (stirring) in the frozen water, after dropwising, leave standstill to solid and all separate out suction filtration, wash with water 3-4 time, on filter paper, obtain white solid, promptly get after the drying purified 2,5-phenylbenzene-1,3, the 4-oxadiazole.Synthetic route is as follows:
Figure G2009100674766D00061
The gained material characterizes as follows through nuclear-magnetism (H-NMR), infrared spectra (IR): H-NMR figure sees Fig. 7, and IR figure sees Fig. 8.
Embodiment 4
2,5-two (4-methyl) phenyl-1,3,4-oxadiazole synthetic.
With 1.36g (10mmol) p-methylbenzoic acid, 5mL SOCl 2, join in the 50mL flask.At 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, airtight flask, in frozen water, stirred 5 minutes.Open wide flask, slowly drip the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, add 20mL water in flask, stirred 30 minutes, suction filtration obtains white solid matter on filter paper.Its drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature, its settled solution slowly is added drop-wise to (stirring) in the frozen water, after dropwising, leave standstill to solid and all separate out suction filtration, wash with water 3-4 time, on filter paper, obtain white solid, promptly get after the drying purified 2,5-two (4-methyl) phenyl-1,3, the 4-oxadiazole.Synthetic route is as follows:
Figure G2009100674766D00062
The gained material characterizes as follows through nuclear-magnetism (H-NMR), infrared spectra (IR): H-NMR figure sees Fig. 9, and IR figure sees Figure 10.

Claims (4)

1. one kind 2,5-two (2-methoxyl group) phenyl-1,3, the synthetic method of 4-oxadiazole, its feature is as follows:
The o-methoxybenzoic acid of 1.52g is added 5mL SOCl 2, 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, airtight being placed in the frozen water stirred 5 minutes; Slowly drip the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, add 20mL water then, stirred 30 minutes, suction filtration obtains white solid matter on filter paper; Drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature slowly is added drop-wise to its settled solution in the frozen water and stirs, and after dropwising, leaves standstill to solid and all separates out, suction filtration washes with water 3-4 time, obtains white solid on filter paper, after the drying promptly.
2. a 5-two (2-thienyl)-1,3, the synthetic method of 4-oxadiazole, its feature is as follows:
The 2-thiophenic acid of 1.28g is added 5mL SOCl 2, at 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, airtight being placed in the frozen water stirred 5 minutes, slowly dripped the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, added 20mL water, stirred 30 minutes, and suction filtration obtains white solid matter on filter paper; Drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature slowly is added drop-wise to its settled solution in the frozen water and stirs, and after dropwising, leaves standstill to solid and all separates out, suction filtration washes with water 3-4 time, obtains white solid on filter paper, after the drying promptly.
3. one kind 2,5-phenylbenzene-1,3, the synthetic method of 4-oxadiazole, its feature is as follows:
The phenylformic acid of 1.22g is added 5mL SOCl 2, at 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, be enclosed in the frozen water and stirred 5 minutes, slowly drip the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, add 20mL water, stirred 30 minutes, suction filtration obtains white solid matter on filter paper; Drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature slowly is added drop-wise to its settled solution in the frozen water and stirs, and after dropwising, leaves standstill to solid and all separates out, suction filtration washes with water 3-4 time, obtains white solid on filter paper, after the drying promptly.
4. one kind 2,5-two (4-methyl) phenyl-1,3, the synthetic method of 4-oxadiazole, its feature is as follows:
The p-methylbenzoic acid of 1.36g is added 5mL SOCl 2, 78 ℃ of following reflux 10 hours, cool to room temperature, decompression steams unnecessary SOCl 2, be enclosed in the frozen water and stirred 5 minutes, slowly drip the hydrazine hydrate of 2mL 80%, at room temperature stirred after dropwising 10 minutes, in flask, add 20mL water, stirred 30 minutes, suction filtration obtains white solid matter on filter paper; Drying is placed in the flask, adds the POCl of 10mL again 3, 100 ℃ of following reflux 10 hours, cool to room temperature slowly is added drop-wise to its settled solution in the frozen water and stirs, and after dropwising, leaves standstill to solid and all separates out, suction filtration washes with water 3-4 time, obtains white solid on filter paper, after the drying promptly.
CN2009100674766A 2009-09-02 2009-09-02 Synthesis method of symmetric 1, 3, 4-oxadiazole Expired - Fee Related CN101643456B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100674766A CN101643456B (en) 2009-09-02 2009-09-02 Synthesis method of symmetric 1, 3, 4-oxadiazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100674766A CN101643456B (en) 2009-09-02 2009-09-02 Synthesis method of symmetric 1, 3, 4-oxadiazole

Publications (2)

Publication Number Publication Date
CN101643456A CN101643456A (en) 2010-02-10
CN101643456B true CN101643456B (en) 2011-11-09

Family

ID=41655542

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100674766A Expired - Fee Related CN101643456B (en) 2009-09-02 2009-09-02 Synthesis method of symmetric 1, 3, 4-oxadiazole

Country Status (1)

Country Link
CN (1) CN101643456B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104628668B (en) * 2015-02-12 2017-03-22 河南科技大学第一附属医院 Synthesis method of pharmaceutical intermediate oxadiazole compound
CN108084109A (en) * 2017-12-21 2018-05-29 南京工业大学 Synthesis method of 2, 5-disubstituted-1, 3, 4-oxadiazole

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Sang Woo Kim, et al..Synthesis and properties of new electroluminescent polymers possessing both hole and electron-transporting units in the main chain.《Polymer》.2002,第43卷第4297-4305页. *
Xiong Gong, et al..Ambipolar Charge Transport in Polymer Light-Emitting Diodes.《J. Phys. Chem. C》.2009,第113卷(第17期),第7398-7404页. *
Yanguang Zhang, et al..Polymer light-emitting diodes based on a bipolar transporting luminescent polymer.《J. Mater. Chem.》.2003,第13卷第773-777. *
孟祥芳.噁二唑型电致发光材料的合成.《中国优秀博硕士学位论文全文数据库(硕士)工程科技I辑》.2005,(第01期),B014-148. *
张立杰.噁二唑类电致发光材料的合成与性能研究.《中国优秀博硕士学位论文全文数据库(硕士)工程科技I辑》.2004,(第04期),B014-130. *

Also Published As

Publication number Publication date
CN101643456A (en) 2010-02-10

Similar Documents

Publication Publication Date Title
Qin et al. TBAI/TBHP catalyzed direct N-acylation of sulfoximines with aldehydes
CN102153557B (en) Chiral center nitrogen heterocyclic carbine precursor salt with quadrol skeleton, synthetic method and application
Shin et al. Synthesis of novel 2, 4, 6, 8, 10-pentaaza [3.3. 3] propellane derivatives
WO2014017516A1 (en) Method of producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazole-3-yl]pyridin-2-carbonitrile, and intermediary thereof
CN105801575A (en) Synthetic method of imidazo[1,2-a]pyridine
CN101265271B (en) Method for synthesizing penem-like pharmaceutical intermediate 4AA
CN101643456B (en) Synthesis method of symmetric 1, 3, 4-oxadiazole
CN115784981A (en) Preparation process of piroctone olamine salt
CN109369610A (en) A kind of synthetic method of cyclobutanol and nitro substituted naphthol class compound
CN108640917A (en) A kind of synthetic method of indoles simultaneously [2,1-a] isoquinoline compound
CN103539775A (en) Dipyridine bridged bis-triazine compounds and preparation method thereof
CN108610278B (en) Synthetic method of 6-amino-5-acyl benzo [ a ] carbazole compound
CN101225056A (en) Alpha-biphenyl-N-alkyl nitrone compound and synthetic method thereof
CN107141258B (en) Method for synthesizing side chain functionalized 4-acylpyrazole compound from cyclic ketohydrazone
CN104356110B (en) A kind of the sulphur induction tetrazine compound of 3,6 aromatic heterocycle Asymmetrical substitute 1,2,4,5 and its synthetic method
KR102174091B1 (en) Method for preparing gamma lactam derivatives from nitrocompound using highly enantioselective bifunctional chiral organocatalytic compound
CN109400611B (en) Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound
CN108558785B (en) 5-aryl-2-arylseleno-1, 3-oxazole compound and preparation method thereof
CN102146113A (en) Method for synthesizing 16 alpha-hydroxy prednisolone
CN113121401B (en) N-substituted carbonyl fluorosulfonamide compound, preparation method and application thereof
CN102000605A (en) Cuprous catalytic initiator Cu2(L)Cl2, preparation method thereof and preparation method of N-heterocyclic aromatized product
CN113354655A (en) Bibenzo [5,6] spiroketal compound and preparation method thereof
CN107915748B (en) Preparation method of 4- (tert-butyl) -1-phenyl-imidazo [4,5,1-kl ] phenoxazine
CN103755617A (en) Method for preparing key impurity of ezetimibe
CN108484503B (en) Preparation method of aryl-substituted pyrazole and derivatives thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111109

Termination date: 20130902